Paper9547669
Multiple resistance modulators combined with carboplatin for resistant malignancies: a pilot study.
Stewart DJ and 5 others. Invest New Drugs, 1997. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Multiple resistance modulators combined with carboplatin for resistant malignancies: a pilot study. Papers, record 9547669. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9547669
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Multiple resistance modulators combined with carboplatin for resistant malignancies: a pilot study.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Carboplatin | Major topic |
| Drug Resistance, Neoplasm | Major topic |
| Neoplasms | Major topic |
| Adult | |
| Aged | |
| Blood Viscosity | |
| Female | |
| Hematologic Diseases | |
| Humans | |
| Male | |
| Middle Aged | |
| Pilot Projects |
Source PubMed
References65
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3048763 | Resistance to cisplatin and analogues: mechanisms and potential clinical implications. | Cancer Chemother Pharmacol | 1988 | https://conductscience.org/library/papers/3048763 | PubMed |
| 2 | 6380349 | Pharmacology of pentoxifylline, a hemorheologic agent for the treatment of intermittent claudication. | Angiology | 1984 | https://conductscience.org/library/papers/6380349 | PubMed |
| 3 | 6422002 | Feasibility study of combining metronidazole with chemotherapy. | J Clin Oncol | 1983 | https://conductscience.org/library/papers/6422002 | PubMed |
| 4 | 3865352 | Antibacterial activity and pharmacokinetics of nitroimidazoles. A review. | Scand J Infect Dis Suppl | 1985 | https://conductscience.org/library/papers/3865352 | PubMed |
| 5 | 3698174 | Altered pharmacokinetics in the mechanism of chemosensitization: effects of nitroimidazoles and other chemical modifiers on the pharmacokinetics, antitumour activity and acute toxicity of selected nitrogen mustards. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3698174 | PubMed |
| 6 | 2118896 | Synergistic effect of cyclosporin A and verapamil in overcoming vincristine resistance of multidrug-resistant cultured human leukemia cells. | Jpn J Cancer Res | 1990 | https://conductscience.org/library/papers/2118896 | PubMed |
| 7 | 1478003 | Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives. | Clin Pharmacokinet | 1992 | https://conductscience.org/library/papers/1478003 | PubMed |
| 8 | 8372807 | Dipyridamole enhancement of drug sensitivity in acute lymphoblastic leukemia cells. | Am J Hematol | 1993 | https://conductscience.org/library/papers/8372807 | PubMed |
| 9 | 7225286 | Cytotoxicity of metronidazole (Flagyl) and misonidazole (Ro-07-0582): enhancement by lactate. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7225286 | PubMed |
| 10 | 9225947 | Association of cisplatin nephrotoxicity with patient characteristics and cisplatin administration methods. | Cancer Chemother Pharmacol | 1997 | https://conductscience.org/library/papers/9225947 | PubMed |
| 11 | 8452101 | Doxorubicin plus metronidazole in the treatment of recurrent or metastatic squamous cell carcinoma of the head and neck. | Am J Clin Oncol | 1993 | https://conductscience.org/library/papers/8452101 | PubMed |
| 12 | 3791559 | 5-Fluorouracil-metronidazole combination therapy in metastatic colorectal cancer. Clinical, pharmacokinetic and in vitro cytotoxicity studies. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3791559 | PubMed |
| 13 | 8174197 | Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/8174197 | PubMed |
| 14 | 1600596 | Synergistic interaction of cyclosporin A and verapamil on vincristine and daunorubicin resistance in multidrug-resistant human leukemia cells in vitro. | Cancer Chemother Pharmacol | 1992 | https://conductscience.org/library/papers/1600596 | PubMed |
| 15 | 7880744 | Factors affecting platinum concentrations in human surgical tumour specimens after cisplatin. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7880744 | PubMed |
| 16 | 2659168 | Non-chemotherapeutic agents that potentiate chemotherapy efficacy. | Cancer Treat Rev | 1989 | https://conductscience.org/library/papers/2659168 | PubMed |
| 17 | 8102639 | Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia. | J Clin Oncol | 1993 | https://conductscience.org/library/papers/8102639 | PubMed |
| 18 | 3282647 | Determinants of tumor blood flow: a review. | Cancer Res | 1988 | https://conductscience.org/library/papers/3282647 | PubMed |
| 19 | 7987990 | Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines by amphotericin B. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/7987990 | PubMed |
| 20 | 2170008 | Induction of the differentiation of WEHI-3B D+ monomyelocytic leukemia cells by inhibitors of topoisomerase II. | Cancer Res | 1990 | https://conductscience.org/library/papers/2170008 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 21983700 | A new synthetic HDAC inhibitor, MHY218, induces apoptosis or autophagy-related cell death in tamoxifen-resistant MCF-7 breast cancer cells. | Invest New Drugs | 2012 | https://conductscience.org/library/papers/21983700 | PubMed |
| 20047843 | Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer. | Crit Rev Oncol Hematol | 2010 | https://conductscience.org/library/papers/20047843 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9547669
GET https://conductscience.org/api/papers/v1/9547669/references?page=2